Capaci Valeria, Mantovani Fiamma, Del Sal Giannino
Dipartimento di Scienze della Vita, Università degli Studi di Trieste, Trieste, Italy.
Cancer Cell Signalling Unit, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Front Oncol. 2021 Jan 11;10:614230. doi: 10.3389/fonc.2020.614230. eCollection 2020.
mutations are widespread in human cancers. An expanding body of evidence highlights that, in addition to their manifold cell-intrinsic activities boosting tumor progression, missense p53 mutants enhance the ability of tumor cells to communicate amongst themselves and with the tumor stroma, by affecting both the quality and the quantity of the cancer secretome. In this review, we summarize recent literature demonstrating that mutant p53 enhances the production of growth and angiogenic factors, inflammatory cytokines and chemokines, modulates biochemical and biomechanical properties of the extracellular matrix, reprograms the cell trafficking machinery to enhance secretion and promote recycling of membrane proteins, and affects exosome composition. All these activities contribute to the release of a promalignant secretome with both local and systemic effects, that is key to the ability of mutant p53 to fuel tumor growth and enable metastatic competence. A precise knowledge of the molecular mechanisms underlying the interplay between mutant p53 and the microenvironment is expected to unveil non-invasive biomarkers and actionable targets to blunt tumor aggressiveness.
突变在人类癌症中广泛存在。越来越多的证据表明,除了其促进肿瘤进展的多种细胞内在活性外,错义p53突变体还通过影响癌症分泌组的质量和数量,增强肿瘤细胞之间以及与肿瘤基质之间相互通讯的能力。在这篇综述中,我们总结了最近的文献,这些文献表明突变型p53增强了生长和血管生成因子、炎性细胞因子和趋化因子 的产生,调节细胞外基质的生化和生物力学特性,重新编程细胞运输机制以增强分泌并促进膜蛋白的循环利用,并影响外泌体的组成。所有这些活动都有助于释放具有局部和全身效应的促恶性分泌组,这是突变型p53推动肿瘤生长和实现转移能力的关键。对突变型p53与微环境之间相互作用的分子机制的精确了解,有望揭示非侵入性生物标志物和可行的靶点,以削弱肿瘤的侵袭性。